fda warning compounding semaglutide october 2025 Warns Novo Nordisk on Unreported Deaths 📢 FDA has determined the

And despite cost concerns, most employers did not experience catastrophic increases in drug spend related to their usage for weight loss (on average +8%)

Protein intake becomes especially important on GLP-1 therapy because significant weight loss can include lean muscle mass if protein intake is inadequate

Statins have made a tremendous impact on saving lives, Khandwalla says

Retatrutide may reshape the landscape of metabolic treatmentsbut for now, all eyes are on the upcoming Phase 3 results

The platform's transparency about what it is - a coordination layer connecting patients with independent clinicians and licensed pharmacies - is consistent with compliant telehealth practice

Lilly is also evaluating orforglipron in late-stage studies in other disease areas like obstructive sleep apnea, osteoarthritis pain of the knee, stress urinary incontinence and hypertension